Prokarium raises $10m for thermostable vaccines – PharmaTimes
PharmaTimes |
Prokarium raises $10m for thermostable vaccines
PharmaTimes UK-based synthetic biology firm Prokarium has secured $10 million from Saudi, Swedish and Korean investors to help drive clinical development of thermostable vaccines. The new funds will enable the clinical development of groundbreaking vaccines … Prokarium closes $10m series B |
